ZENTEK LTD (ZEN.CA) Stock Fundamental Analysis
TSX-V:ZEN - CA98942X1024 - Common Stock
0.91 CAD
0 (0%)
Overall ZEN gets a fundamental rating of 3 out of 10. We evaluated ZEN against 16 industry peers in the Health Care Equipment & Supplies industry. While ZEN seems to be doing ok healthwise, there are quite some concerns on its profitability. ZEN is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ZEN has reported negative net income.
ZEN had a negative operating cash flow in the past year.
In the past 5 years ZEN always reported negative net income.
In the past 5 years ZEN always reported negative operating cash flow.
1.2 Ratios
ZEN has a better Return On Assets (-54.57%) than 81.25% of its industry peers.
Looking at the Return On Equity, with a value of -68.07%, ZEN belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -54.57% | ||
| ROE | -68.07% | ||
| ROIC | N/A |
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ZEN's Gross Margin of 22.06% is on the low side compared to the rest of the industry. ZEN is outperformed by 68.75% of its industry peers.
The Profit Margin and Operating Margin are not available for ZEN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ZEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZEN has more shares outstanding
Compared to 5 years ago, ZEN has more shares outstanding
ZEN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 7.68 indicates that ZEN is not in any danger for bankruptcy at the moment.
ZEN's Altman-Z score of 7.68 is amongst the best of the industry. ZEN outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ZEN is not too dependend on debt financing.
ZEN has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. ZEN outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 7.68 |
ROIC/WACCN/A
WACC8.08%
2.3 Liquidity
A Current Ratio of 1.25 indicates that ZEN should not have too much problems paying its short term obligations.
ZEN has a better Current ratio (1.25) than 68.75% of its industry peers.
ZEN has a Quick Ratio of 1.25. This is a bad value and indicates that ZEN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ZEN (1.00) is better than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.25 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
ZEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.11%, which is quite good.
The Revenue has grown by 2827.85% in the past year. This is a very strong growth!
Measured over the past years, ZEN shows a very strong growth in Revenue. The Revenue has been growing by 35.95% on average per year.
EPS 1Y (TTM)16.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.46%
Revenue 1Y (TTM)2827.85%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%13927.59%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ZEN. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ZEN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:ZEN (8/29/2025, 7:00:00 PM)
0.91
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.51%
Inst Owner ChangeN/A
Ins Owners5.84%
Ins Owner ChangeN/A
Market Cap95.29M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 109.21 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 6.46 | ||
| P/tB | 6.46 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.01
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -54.57% | ||
| ROE | -68.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.06% | ||
| FCFM | N/A |
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 30.75% | ||
| Cap/Sales | 21.16% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.25 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 7.68 |
F-Score4
WACC8.08%
ROIC/WACCN/A
Cap/Depr(3y)182.79%
Cap/Depr(5y)454.82%
Cap/Sales(3y)1708.52%
Cap/Sales(5y)12638%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2827.85%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%13927.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.97%
OCF growth 3YN/A
OCF growth 5YN/A